Shopping Cart 0
Cart Subtotal
USD 0

C-Rad AB (CRAD B) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, catalyst Tomo, catalyst PT, Cypra laser, and Gemini products. C-Rad's senitel products provide a surface contour laser scanning system for patient positioning, monitoring and gating applications. The company's Gemini product is a detector system used for tumor localization. It provides installation, application training, and aftersales services. The markets its products through a network of distributors in Sweden, Korea, India, Thailand, China, Taiwan, Poland, Belgium, the Netherlands, Spain, France, the UK, and others. C-Rad is headquartered in Uppsala, Sweden.

C-Rad AB (CRAD B)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6

C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

C-Rad AB, Medical Equipment, Deal Details 10

Partnerships 10

GE Healthcare Enters into Distribution Agreement with C-Rad 10

Equity Offering 11

C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11

C-RAD Raises USD5.4 Million in Rights Offering of Shares 12

C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14

Acquisition 15

C-Rad Acquires Remaining 71% Stake in Cyrpa International 15

C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17

C-Rad AB-Key Competitors 18

C-Rad AB-Key Employees 19

C-Rad AB-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Financial Announcements 21

Aug 17, 2018: C-RAD-Interim report January-June 2018 21

Apr 26, 2018: C-RAD: Interim report January-March 2018 22

Jan 31, 2018: C-RAD AB-Consolidated Year-End report January-December 2017 23

Oct 27, 2017: C-RAD-Interim report January-September 2017 24

Corporate Communications 25

Aug 14, 2018: C-RAD has appointed Cecilia Danckwardt-Lilliestrom as new CFO 25

Legal and Regulatory 26

Jun 20, 2017: Appeal Court final resolution of dispute over C-RAD's entitlement to patents 26

Other Significant Developments 27

Dec 13, 2017: Update on C-RAD delivery of its advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna 27

Jan 30, 2017: C-RAD and MD Anderson Cancer Center concluded agreement to supply innovative SIGRT solution 28

Appendix 29

Methodology 29

About GlobalData 29

Contact Us 29

Disclaimer 29


List Of Figure

List of Figures

C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

C-Rad AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

C-Rad AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

C-Rad AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

C-Rad AB, Medical Equipment, Key Facts, 2017 2

C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

C-Rad AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

C-Rad AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6

C-Rad AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

C-Rad AB, Deals By Market, 2012 to YTD 2018 8

C-Rad AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

GE Healthcare Enters into Distribution Agreement with C-Rad 10

C-Rad Raises USD2.5 Million in Private Placement of Series B Shares 11

C-RAD Raises USD5.4 Million in Rights Offering of Shares 12

C-RAD to Raise USD3 Million in Rights Offering of Series B Shares 14

C-Rad Acquires Remaining 71% Stake in Cyrpa International 15

C-Rad Acquired 29% Stake In Cyrpa International, Radiotherapy Products Developer, For USD1.4 Million 17

C-Rad AB, Key Competitors 18

C-Rad AB, Key Employees 19

C-Rad AB, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

C-Rad AB, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.